Evaluation of nanoarchitectured collagen type II molecules on cartilage engineering
Source abstract
Abstract
Abstract Scaffold architecture, including the geometry and dimension of scaffolds, is an important parameter in cell adhesion, migration, proliferation, and differentiation. Following the characterization of collagen type II nanoarchitectured molecules, collagen fibrils (CNFs) and collagen spheres (CNPs) prepared using a high‐voltage electric field in our laboratory, we proposed to use these nanoarchitectured molecules to assess their influence on the culturing of chondrocytes in stirred bioreactors. The results demonstrate that chondrocytes rapidly formed more and larger chondrocyte pellets (spheroids) after the addition of nanoarchitectured molecules into the culture medium. The maintenance of chondrocytes with round morphology and increased glycosaminoglycan secretion indicated that these spheroids contained viable and un‐dedifferentiated chondrocytes. No significant increases in DNA content were detected. These results show that the introduction of these molecules did not affect chondrocyte proliferation during a 3‐day culture period. After the addition of CNPs and CNFs into the culture medium, the expression levels of collagen type II and aggrecan genes in chondrocytes increased significantly as demonstrated by real‐time PCR analysis. Interestingly, chondrocytes exhibited distinct collagen type II and aggrecan gene expression profiles in culture with CNPs and CNFs. The aggrecan gene expression level of the chondrocytes was 2.5‐fold greater following CFN addition than following the addition of CNPs. In contrast, the collagen type II expression level of the chondrocytes was 2.2‐fold greater following the addition of CNPs than following the addition of CNFs. The chondrocyte pellets rapidly restored defects in articular cartilage during a 1‐month implantation period in a rabbit model. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Collagen: Extraction and Characterization · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. 10.1002/jcp.1047110.1002/jcp.10471 ↗
2. 10.1016/B978-0-12-775170-2.50009-310.1016/B978-0-12-775170-2.50009-3 ↗
3. 10.1146/annurev.cellbio.12.1.69710.1146/annurev.cellbio.12.1.697 ↗
4. 10.1016/j.addr.2003.08.00210.1016/j.addr.2003.08.002 ↗
5. 10.1002/(SICI)1097-4644(19960501)61:2<246::AID-JCB8>3.0.CO;2-U10.1002/(SICI)1097-4644(19960501)61:2<246::AID-JCB8>3.0.CO;2-U ↗
6. 10.1016/j.biomaterials.2010.03.05810.1016/j.biomaterials.2010.03.058 ↗
7. 10.1016/j.biomaterials.2010.01.03410.1016/j.biomaterials.2010.01.034 ↗
8. 10.1089/ten.2006.12.177510.1089/ten.2006.12.1775 ↗
9. 10.1016/S0142-9612(02)00067-410.1016/S0142-9612(02)00067-4 ↗
10. 10.1016/j.joca.2008.02.01410.1016/j.joca.2008.02.014 ↗
11. 10.1002/jbm.1014710.1002/jbm.10147 ↗
12. 10.1016/j.jbiosc.2008.09.02010.1016/j.jbiosc.2008.09.020 ↗
13. 10.1049/ip-nbt:2005003710.1049/ip-nbt:20050037 ↗
14. 10.1016/j.actbio.2008.08.00210.1016/j.actbio.2008.08.002 ↗
15. 10.1053/joca.2001.048210.1053/joca.2001.0482 ↗
16. 10.1016/j.orthres.2004.08.00810.1016/j.orthres.2004.08.008 ↗
17. 10.1016/j.biomaterials.2004.01.04410.1016/j.biomaterials.2004.01.044 ↗
18. 10.22203/eCM.v021a4210.22203/eCM.v021a42 ↗
19. 10.1006/excr.1994.112310.1006/excr.1994.1123 ↗
20. 10.1053/joca.2001.047710.1053/joca.2001.0477 ↗
21. 10.1089/10763270332249558310.1089/107632703322495583 ↗
22. 10.22203/eCM.v017a0110.22203/eCM.v017a01 ↗
23. 10.1006/excr.1998.401010.1006/excr.1998.4010 ↗
24. 10.1002/jbm.82027010410.1002/jbm.820270104 ↗
25. 10.1016/j.actbio.2008.09.02010.1016/j.actbio.2008.09.020 ↗